ENTRY       mmu04935                    Pathway
NAME        Growth hormone synthesis, secretion and action - Mus musculus (mouse)
DESCRIPTION Growth hormone (GH) is a peptide hormone secreted from the anterior pituitary and plays a critical role in cell growth, development, and metabolism throughout the body. GH secretion occurs episodically and is primarily under the control of two hypothalamic neuroendocrine hormones: GH-releasing hormone (GHRH), which stimulates GH secretion, and somatostatin, which inhibits GH secretion. GHRH interacts with a G protein-coupled receptor (GHRHR) in somatotroph cells to activate the cAMP signaling pathway, which leads to increased GH mRNA transcription and release. Once released into the circulation, GH binds to cell-surface GHR in target tissues such as liver, muscle, bone, and adipose tissue. Binding leads to activation of JAK2 that in turn triggers an array of signaling cascade including Raf-MEK-ERK, PI3K-Akt, and STAT5. ERK, Akt, and STAT5 all promote growth via the synthesis and secretion of IGF-1.
CLASS       Organismal Systems; Endocrine system
PATHWAY_MAP mmu04935  Growth hormone synthesis, secretion and action
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        14601  Ghrh; growth hormone releasing hormone [KO:K05260]
            14602  Ghrhr; growth hormone releasing hormone receptor [KO:K04584]
            14683  Gnas; GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus [KO:K04632]
            432530  Adcy1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
            210044  Adcy2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
            104111  Adcy3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            104110  Adcy4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            224129  Adcy5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            11512  Adcy6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
            11513  Adcy7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            11514  Adcy8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
            11515  Adcy9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            271639  Adcy10; adenylate cyclase 10 [KO:K11265] [EC:4.6.1.1]
            20604  Sst; somatostatin [KO:K05237]
            20605  Sstr1; somatostatin receptor 1 [KO:K04217]
            20606  Sstr2; somatostatin receptor 2 [KO:K04218]
            20607  Sstr3; somatostatin receptor 3 [KO:K04219]
            20609  Sstr5; somatostatin receptor 5 [KO:K04221]
            14677  Gnai1; guanine nucleotide binding protein (G protein), alpha inhibiting 1 [KO:K04630]
            14679  Gnai3; guanine nucleotide binding protein (G protein), alpha inhibiting 3 [KO:K04630]
            14678  Gnai2; guanine nucleotide binding protein (G protein), alpha inhibiting 2 [KO:K04630]
            18747  Prkaca; protein kinase, cAMP dependent, catalytic, alpha [KO:K04345] [EC:2.7.11.11]
            18749  Prkacb; protein kinase, cAMP dependent, catalytic, beta [KO:K04345] [EC:2.7.11.11]
            12912  Creb1; cAMP responsive element binding protein 1 [KO:K05870]
            11909  Atf2; activating transcription factor 2 [KO:K04450]
            11911  Atf4; activating transcription factor 4 [KO:K04374]
            12913  Creb3; cAMP responsive element binding protein 3 [KO:K09048]
            26427  Creb3l1; cAMP responsive element binding protein 3-like 1 [KO:K09048]
            208647  Creb3l2; cAMP responsive element binding protein 3-like 2 [KO:K09048]
            208677  Creb3l3; cAMP responsive element binding protein 3-like 3 [KO:K09048]
            78284  Creb3l4; cAMP responsive element binding protein 3-like 4 [KO:K09048]
            231991  Creb5; cAMP responsive element binding protein 5 [KO:K09047]
            12915  Atf6b; activating transcription factor 6 beta [KO:K09049]
            12914  Crebbp; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            328572  Ep300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            18736  Pou1f1; POU domain, class 1, transcription factor 1 [KO:K09363]
            14281  Fos; FBJ osteosarcoma oncogene [KO:K04379]
            14599  Gh; growth hormone [KO:K05438]
            58991  Ghrl; ghrelin [KO:K05254]
            208188  Ghsr; growth hormone secretagogue receptor [KO:K04284]
            14682  Gnaq; guanine nucleotide binding protein, alpha q polypeptide [KO:K04634]
            14672  Gna11; guanine nucleotide binding protein, alpha 11 [KO:K04635]
            18795  Plcb1; phospholipase C, beta 1 [KO:K05858] [EC:3.1.4.11]
            18797  Plcb3; phospholipase C, beta 3 [KO:K05858] [EC:3.1.4.11]
            18798  Plcb4; phospholipase C, beta 4 [KO:K05858] [EC:3.1.4.11]
            18796  Plcb2; phospholipase C, beta 2 [KO:K05858] [EC:3.1.4.11]
            18750  Prkca; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
            18751  Prkcb; protein kinase C, beta [KO:K19662] [EC:2.7.11.13]
            18752  Prkcg; protein kinase C, gamma [KO:K19663] [EC:2.7.11.13]
            16438  Itpr1; inositol 1,4,5-trisphosphate receptor 1 [KO:K04958]
            16439  Itpr2; inositol 1,4,5-triphosphate receptor 2 [KO:K04959]
            16440  Itpr3; inositol 1,4,5-triphosphate receptor 3 [KO:K04960]
            12292  Cacna1s; calcium channel, voltage-dependent, L type, alpha 1S subunit [KO:K04857]
            12288  Cacna1c; calcium channel, voltage-dependent, L type, alpha 1C subunit [KO:K04850]
            12289  Cacna1d; calcium channel, voltage-dependent, L type, alpha 1D subunit [KO:K04851]
            54652  Cacna1f; calcium channel, voltage-dependent, alpha 1F subunit [KO:K04853]
            14600  Ghr; growth hormone receptor [KO:K05080]
            16452  Jak2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]
            18803  Plcg1; phospholipase C, gamma 1 [KO:K01116] [EC:3.1.4.11]
            234779  Plcg2; phospholipase C, gamma 2 [KO:K05859] [EC:3.1.4.11]
            20416  Shc1; src homology 2 domain-containing transforming protein C1 [KO:K06279]
            216148  Shc2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K17447]
            20418  Shc3; src homology 2 domain-containing transforming protein C3 [KO:K17448]
            271849  Shc4; SHC (Src homology 2 domain containing) family, member 4 [KO:K17449]
            14784  Grb2; growth factor receptor bound protein 2 [KO:K04364]
            20662  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            20663  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            15461  Hras; Harvey rat sarcoma virus oncogene [KO:K02833]
            16653  Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            18176  Nras; neuroblastoma ras oncogene [KO:K07828]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            26396  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            20846  Stat1; signal transducer and activator of transcription 1 [KO:K11220]
            20848  Stat3; signal transducer and activator of transcription 3 [KO:K04692]
            20850  Stat5a; signal transducer and activator of transcription 5A [KO:K11223]
            20851  Stat5b; signal transducer and activator of transcription 5B [KO:K11224]
            16367  Irs1; insulin receptor substrate 1 [KO:K16172]
            384783  Irs2; insulin receptor substrate 2 [KO:K07187]
            16369  Irs3; insulin receptor substrate 3 [KO:K17445]
            16370  Irs4; insulin receptor substrate 4 [KO:K17446]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            56717  Mtor; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            56637  Gsk3b; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            16000  Igf1; insulin-like growth factor 1 [KO:K05459]
            16477  Junb; jun B proto-oncogene [KO:K09028]
            12703  Socs1; suppressor of cytokine signaling 1 [KO:K04694]
            216233  Socs2; suppressor of cytokine signaling 2 [KO:K04695]
            12702  Socs3; suppressor of cytokine signaling 3 [KO:K04696]
            16005  Igfals; insulin-like growth factor binding protein, acid labile subunit [KO:K17256]
            16009  Igfbp3; insulin-like growth factor binding protein 3 [KO:K10138]
            14083  Ptk2; PTK2 protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
            12927  Bcar1; breast cancer anti-estrogen resistance 1 [KO:K05726]
            12928  Crk; v-crk avian sarcoma virus CT10 oncogene homolog [KO:K04438]
            12929  Crkl; v-crk avian sarcoma virus CT10 oncogene homolog-like [KO:K04438]
            26401  Map3k1; mitogen-activated protein kinase kinase kinase 1 [KO:K04416] [EC:2.7.11.25]
            26397  Map2k3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            26398  Map2k4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            26399  Map2k6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            26419  Mapk8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            26420  Mapk9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            26414  Mapk10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            26416  Mapk14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            19094  Mapk11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            29857  Mapk12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            26415  Mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
REFERENCE   
  AUTHORS   Nishad R, Mukhi D, Menon R K, Pasupulati A.
  TITLE     Growth Hormone and Metabolic Homeostasis
  JOURNAL   European Medical Journal 6(1):78-87 (2018)
REFERENCE   PMID:30775002
  AUTHORS   Lu M, Flanagan JU, Langley RJ, Hay MP, Perry JK
  TITLE     Targeting growth hormone function: strategies and therapeutic applications.
  JOURNAL   Signal Transduct Target Ther 4:3 (2019)
            DOI:10.1038/s41392-019-0036-y
REFERENCE   PMID:8874495
  AUTHORS   Argetsinger LS, Carter-Su C
  TITLE     Mechanism of signaling by growth hormone receptor.
  JOURNAL   Physiol Rev 76:1089-107 (1996)
            DOI:10.1152/physrev.1996.76.4.1089
REFERENCE   PMID:8815791
  AUTHORS   Carter-Su C, Schwartz J, Smit LS
  TITLE     Molecular mechanism of growth hormone action.
  JOURNAL   Annu Rev Physiol 58:187-207 (1996)
            DOI:10.1146/annurev.ph.58.030196.001155
REFERENCE   PMID:10912517
  AUTHORS   Carter-Su C, Rui L, Herrington J
  TITLE     Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.
  JOURNAL   Pediatr Nephrol 14:550-7 (2000)
            DOI:10.1007/s004670000366
REFERENCE   PMID:29487568
  AUTHORS   Dehkhoda F, Lee CMM, Medina J, Brooks AJ
  TITLE     The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.
  JOURNAL   Front Endocrinol (Lausanne) 9:35 (2018)
            DOI:10.3389/fendo.2018.00035
REFERENCE   PMID:26421979
  AUTHORS   Carter-Su C, Schwartz J, Argetsinger LS
  TITLE     Growth hormone signaling pathways.
  JOURNAL   Growth Horm IGF Res 28:11-5 (2016)
            DOI:10.1016/j.ghir.2015.09.002
REFERENCE   PMID:28435436
  AUTHORS   Berryman DE, Henry B, Hjortebjerg R, List EO, Kopchick JJ
  TITLE     Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.
  JOURNAL   Expert Rev Endocrinol Metab 11:197-207 (2016)
            DOI:10.1586/17446651.2016.1147950
REFERENCE   PMID:9837978
  AUTHORS   Zhu T, Goh EL, LeRoith D, Lobie PE
  TITLE     Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK).
  JOURNAL   J Biol Chem 273:33864-75 (1998)
            DOI:10.1074/jbc.273.50.33864
REFERENCE   
  AUTHORS   Choi S (ed).
  TITLE     Encyclopedia of Signaling Molecules
  JOURNAL   Springer International Publishing
            DOI:10.1007/978-1-4614-6438-9_101674-1
REFERENCE   PMID:11997217
  AUTHORS   Gracia-Navarro F, Castano JP, Malagon MM, Sanchez-Hormigo A, Luque RM, Hickey GJ, Peinado JR, Delgado E, Martinez-Fuentes AJ
  TITLE     Research progress in the stimulatory inputs regulating growth hormone (GH) secretion.
  JOURNAL   Comp Biochem Physiol B Biochem Mol Biol 132:141-50 (2002)
            DOI:10.1016/s1096-4959(01)00544-9
REFERENCE   PMID:9167959
  AUTHORS   Bertherat J
  TITLE     Nuclear effects of the cAMP pathway activation in somatotrophs.
  JOURNAL   Horm Res 47:245-50 (1997)
            DOI:10.1159/000185471
REFERENCE   PMID:8625613
  AUTHORS   Tuggle CK, Trenkle A
  TITLE     Control of growth hormone synthesis.
  JOURNAL   Domest Anim Endocrinol 13:1-33 (1996)
            DOI:10.1016/0739-7240(95)00059-3
REFERENCE   PMID:10525051
  AUTHORS   Cohen LE, Hashimoto Y, Zanger K, Wondisford F, Radovick S
  TITLE     CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression.
  JOURNAL   J Clin Invest 104:1123-30 (1999)
            DOI:10.1172/JCI7308
REFERENCE   PMID:25302229
  AUTHORS   Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D, Zahiruddin QS
  TITLE     Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion.
  JOURNAL   J Clin Diagn Res 8:MC13-7 (2014)
            DOI:10.7860/JCDR/2014/9863.4767
REFERENCE   PMID:16628271
  AUTHORS   Lengyel AM
  TITLE     From growth hormone-releasing peptides to ghrelin: discovery of new modulators of GH secretion.
  JOURNAL   Arq Bras Endocrinol Metabol 50:17-24 (2006)
            DOI:10.1590/s0004-27302006000100004
REFERENCE   PMID:15927771
  AUTHORS   Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A
  TITLE     Physiology of ghrelin and related peptides.
  JOURNAL   Domest Anim Endocrinol 29:111-44 (2005)
            DOI:10.1016/j.domaniend.2005.02.033
REFERENCE   PMID:14610293
  AUTHORS   Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C, Casanueva FF
  TITLE     Regulation of ghrelin secretion and action.
  JOURNAL   Endocrine 22:5-12 (2003)
            DOI:10.1385/ENDO:22:1:5
REFERENCE   PMID:22243899
  AUTHORS   Yang SK, Steyn F, Chen C
  TITLE     Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators.
  JOURNAL   Cell Calcium 51:231-9 (2012)
            DOI:10.1016/j.ceca.2011.12.005
REFERENCE   PMID:19884662
  AUTHORS   Melmed S
  TITLE     Acromegaly pathogenesis and treatment.
  JOURNAL   J Clin Invest 119:3189-202 (2009)
            DOI:10.1172/JCI39375
REL_PATHWAY mmu04010  MAPK signaling pathway
            mmu04020  Calcium signaling pathway
            mmu04024  cAMP signaling pathway
            mmu04630  JAK-STAT signaling pathway
KO_PATHWAY  ko04935
///
